drugset / Trial / NCT00937417

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

NCT00937417

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Vandetanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving vandetanib together with docetaxel may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vandetanib given together with docetaxel in treating patients with advanced solid tumors.

Timeline

Start
2008-09
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vandetanib Small molecule Oral
Background Docetaxel Small molecule Intravenous